+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nebulizer Market Size, Share & Trends Analysis Report by Type (Jet, Mesh, Ultrasonic), by End Use (Hospitals and Clinics, Emergency Centers), by Region (North America, Europe, APAC, Latin America, MEA), and Segment Forecasts, 2020 - 2027

  • ID: 4479663
  • Report
  • February 2020
  • Region: North America, Europe, Asia Pacific
  • 100 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BD
  • Beurer GmBH
  • Briggs Healthcare
  • GF Health Products, Inc.
  • Koninklijke Philips N.V.
  • Medline Industries, Inc.
  • MORE
The global nebulizer market size is expected to reach USD 1.5 billion by 2027, expanding at a CAGR of 6.6% over the forecast period. Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to market growth.

According to the Population Reference Bureau report, 'Aging in the United States', the geriatric population in the U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

On the other hand, drug loss during nebulization is the major factor restraining the market. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss. Furthermore, increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth.

Technological advancements such as drug-device combination is further expected to create new opportunity in the market. The key manufacturers are expected to dominate the market of drug device combinations till the generic mesh nebulizer manufacturers invest in the support infrastructure required for the development of new pharmaceuticals. For instance, in 2016, Sunovion filed the first application for the approval of SUN-101. A mesh nebulizer in combination with a drug for COPD (SUN-101) will be a significant step for boosting the adoption of nebulizers. Other companies such as Vectura also have products in late stage development, e.g., VR475, indicated for severe asthma, in Phase III trials.

Further key findings from the study suggest:
  • The jet segment held over 60.0% market share in 2019 owing to the greater penetration and low cost of the devices
  • The mesh segment is expected to be the fastest growing segment with a CAGR of 7.7% over the forecast period, due to various benefits including portability, convenience, homecare application, and accurate dosage delivery
  • According to the Population Reference Bureau report, 'Aging in the United States', the geriatric population in the U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060
  • The demand is expected to increase in homecare application. Easy availability of compact nebulizers that are ideal for home use and technological innovations in the device to reduce the sound created by it and to improve its functionality are increasing its adoption in home healthcare
  • North America dominated the nebulizer market in 2019. This high share can be attributed to increase in incidence of respiratory diseases, supportive government policies, favorable reimbursement schemes, rise in awareness, and increasing use of home care products
  • As per the analysis of the U.S. and EU clinical trial databases, mesh nebulizers are more preferred for clinical trials sponsored by pharmaceutical companies over jet nebulizers
  • Key players include Omron Corporation, Koninklijke Philips N.V., PARI Pharma, Allied Healthcare Products, Inc., Becton Dickinson and Company, Agilent Technologies, Medline Industries, Briggs Healthcare, Drive Medical, and GF Health Products, Inc.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BD
  • Beurer GmBH
  • Briggs Healthcare
  • GF Health Products, Inc.
  • Koninklijke Philips N.V.
  • Medline Industries, Inc.
  • MORE
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Type
1.1.2 End use
1.1.3 Regional scope
1.1.4 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Outlook

Chapter 3 Nebulizer Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Market influencer analysis
3.4 List of Key End Users
3.5 Regulatory Framework
3.5.1 Regulatory Landscape
3.6 Technology Overview
3.6.1 Nebulizer timeline analysis
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Rising incidence of chronic respiratory diseases
3.7.1.2 Increasing demand for home healthcare devices
3.7.1.3 Expanding geriatric population base and increasing use of porTable nebulizers
3.7.2 Market restrain analysis
3.7.2.1 Drug loss during drug delivery
3.7.2.2 Availability of nebulizer substitute
3.8 Nebulizer Analysis Tools: Porter’s
3.8.1 Supplier Power
3.8.2 Buyer Power
3.8.3 Threat of Substitutes
3.8.4 Threat of New Entrants
3.8.5 Competitive Rivalry
3.9 Nebulizer Market - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
3.9.1 Political Landscape
3.9.2 Economic Landscape
3.9.3 Social Landscape
3.9.4 Technology Landscape
3.9.5 Legal Landscape
3.9.6 Respiratory Disease Prevalence
3.9.7 Major Deals and Strategic Alliances

Chapter 4 Nebulizer Market: Competitive Analysis
4.1 Market Participation Categorization
4.2 Competitive Analysis
4.2.1 Company market position analysis
4.2.2 Market leader
4.2.3 Innovators
4.2.4 Vendor Landscape
4.2.4.1 List of nebulizer service providers

Chapter 5 Nebulizer Market: Segment Analysis, by Type, 2016 - 2027 (USD Million)
5.1 Definition and Scope
5.2 Type Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Nebulizer Market, by Type, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.5.1 Jet nebulizer
5.5.1.1 Jet nebulizer market, 2016 - 2027 (USD Million)
5.5.2 Mesh nebulizer
5.5.2.1 Mesh nebulizer market, 2016 - 2027 (USD Million)
5.5.3 Ultrasonic nebulizer
5.5.3.1 Ultrasonic nebulizer market, 2016 - 2027 (USD Million)

Chapter 6 Nebulizer Market: Segment Analysis, by End Use, 2016 - 2027 (USD Million)
6.1 Definition and Scope
6.2 End Use Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Nebulizer Market, by End Use, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.5.1 Hospitals and Clinics
6.5.1.1 Hospitals and Clinics market, 2016 - 2027 (USD Million)
6.5.2 Emergency Centers
6.5.2.1 Emergency Centers market, 2016 - 2027 (USD Million)
6.5.3 Home Healthcare
6.5.3.1 Home Healthcare market, 2016 - 2027 (USD Million)

Chapter 7 Nebulizer Market: Regional Market Analysis, by Type and End Use, 2016 - 2027 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2019 & 2027
7.3 Regional Market Dashboard
7.4 Global Nebulizer Market, by Regions, 2016 to 2027
7.5 Regional Market Snapshot
7.6 Market Size, & Forecasts, Volume and Trend Analysis, 2016 to 2027
7.7 North America
7.7.1 North America Market estimates and forecast, by country, 2016-2027 (USD Million)
7.7.2 North America Nebulizer market, by type, 2016 - 2027 (USD Million)
7.7.3 North America Nebulizer market, by end use, 2016 - 2027 (USD Million)
7.7.4 U.S.
7.7.4.1 U.S. Nebulizer market, 2016 - 2027 (USD Million)
7.7.5 Canada
7.7.5.1 Canada Nebulizer market, 2016 - 2027 (USD Million)
7.8 Europe
7.8.1 Europe Nebulizer market, by country, 2016 - 2027 (USD Million)
7.8.2 Europe Nebulizer market, by type, 2016 - 2027 (USD Million)
7.8.3 Europe Nebulizer market, by end use, 2016 - 2027 (USD Million)
7.8.4 U.K.
7.8.4.1 U.K. Nebulizer market, 2016 - 2027 (USD Million)
7.8.5 Germany
7.8.5.1 Germany Nebulizer market, 2016 - 2027 (USD Million)
7.8.6 France
7.8.6.1 France Nebulizer market, 2016 - 2027 (USD Million)
7.8.7 Italy
7.8.7.1 Italy Nebulizer market, 2016 - 2027 (USD Million)
7.8.8 Spain
7.8.8.1 Spain Nebulizer market, 2016 - 2027 (USD Million)
7.8.9 Russia
7.8.9.1 Russia Nebulizer market, 2016 - 2027 (USD Million)
7.9 Asia Pacific
7.9.1 Asia Pacific Nebulizer market, by country, 2016 - 2027 (USD Million)
7.9.2 Asia Pacific Nebulizer market, by type, 2016 - 2027 (USD Million)
7.9.3 Asia Pacific Nebulizer market, by end use, 2016 - 2027 (USD Million)
7.9.4 Japan
7.9.4.1 Japan Nebulizer market, 2016 - 2027 (USD Million)
7.9.5 China
7.9.5.1 China Nebulizer market, 2016 - 2027 (USD Million)
7.9.6 India
7.9.6.1 India Nebulizer market, 2016 - 2027 (USD Million)
7.9.7 Malaysia
7.9.7.1 Malaysia Nebulizer market, 2016 - 2027 (USD Million)
7.9.8 Singapore
7.9.8.1 Singapore Nebulizer market, 2016 - 2027 (USD Million)
7.9.9 Philippines
7.9.9.1 Philippines Nebulizer market, 2016 - 2027 (USD Million)
7.9.10 Indonesia
7.9.10.1 Indonesia Nebulizer market, 2016 - 2027 (USD Million)
7.10 Latin America
7.10.1 Latin America Nebulizer market, by country, 2016 - 2027 (USD Million)
7.10.2 Latin America Nebulizer market, by type, 2016 - 2027 (USD Million)
7.10.3 Latin America Nebulizer market, by end use, 2016 - 2027 (USD Million)
7.10.4 Brazil
7.10.4.1 Brazil Nebulizer market, 2016 - 2027 (USD Million)
7.10.5 Mexico
7.10.5.1 Mexico Nebulizer market, 2016 - 2027 (USD Million)
7.11 MEA
7.11.1 MEA Nebulizer market, by country 2016 - 2027 (USD Million)
7.11.2 MEA Nebulizer market, by type, 2016 - 2027 (USD Million)
7.11.3 MEA Nebulizer market, by end use, 2016 - 2027 (USD Million)
7.11.4 South Africa
7.11.4.1 South Africa Nebulizer market, 2016 - 2027 (USD Million)

Chapter 8 Nebulizer Market - Competitive Analysis
8.1 Rossmax International Ltd.
8.1.1 Company Overview
8.1.2 Product Benchmarking
8.1.3 Strategic Initiatives
8.2 OMRON Corporation
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 Koninklijke Philips N.V.
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 PARI Pharma
8.4.1 Company overview
8.4.2 Product benchmarking
8.4.3 Strategic initiatives
8.5 BD
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 Medline Industries, Inc.
8.6.1 Company overview
8.6.2 Product benchmarking
8.6.3 Strategic initiatives
8.7 Briggs Healthcare
8.7.1 Company overview
8.7.2 Product benchmarking
8.7.3 Strategic initiatives
8.8 GF Health Products, Inc.
8.8.1 Company overview
8.8.2 Product benchmarking
8.8.3 Strategic initiatives
8.9 Vectura Group plc
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Beurer GmBH
8.10.1 Company Overview
8.10.2 Product Benchmarking
8.10.3 Strategic Initiatives
8.10.4 KOL commentary


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Rossmax International Ltd.
  • OMRON Corporation
  • Koninklijke Philips N.V.
  • PARI Pharma
  • BD
  • Medline Industries, Inc.
  • Briggs Healthcare
  • GF Health Products, Inc.
  • Vectura Group plc
  • Beurer GmBH
Note: Product cover images may vary from those shown
Adroll
adroll